Loading…

Acute Toxicity of Ethyl Acetate Fraction of Kaempferia galanga L. Rhizome

The Kaempferia galanga L. (KG) rhizome has a long history of being used as a variety of anti-inflammatory, analgesic, antioxidant, sedative, antibacterial, and anti-cancer compounds. The KG rhizomes have the potential to be an effective complementary medicine, but their use must be completely safe....

Full description

Saved in:
Bibliographic Details
Published in:IOP conference series. Earth and environmental science 2023-09, Vol.1242 (1), p.12007
Main Authors: Siska, S, Bariroh, T, Supandi, S
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The Kaempferia galanga L. (KG) rhizome has a long history of being used as a variety of anti-inflammatory, analgesic, antioxidant, sedative, antibacterial, and anti-cancer compounds. The KG rhizomes have the potential to be an effective complementary medicine, but their use must be completely safe. This study examines the acute toxicity of the ethyl acetate fraction of KG (EAFKG) with parameters of blood chemistry value, and liver and kidney histological morphology. 40 DDY strain mice, consisting of males and females with weights ranging from 20-35 g, were used in this study. The mice are divided into four groups for each sex. Groups 1, 2, 3, and 4 received the EAFKG at a dose of 0.128; 0.64; 3.2; and 16 g/Kg BW, respectively, and were administered orally. Observations are carried out for 24 hours. The levels of serum creatinine, AST, and ALT were detected with a clinical spectrophotometer. According to the test results, both male and female mouse groups had no fatalities. The EAFKG rhizome is practically non-toxic (LD 50 > 15 g/Kg BW). There is no significant difference in AST, ALT, and serum creatinine levels at any dose group than the control group. EAFKG administration affects liver and kidney cells at high doses but does not cause lethality.
ISSN:1755-1307
1755-1315
DOI:10.1088/1755-1315/1242/1/012007